Soleo Health launches rare disease specialty pharmacy

FRISCO, Texas – Soleo Health has launched SoleoRare, a dedicated rare disease specialty pharmacy.

The new brand brings together experienced rare disease patient care, patient access and commercial teams under a differentiated care model that is clinician‑led, patient‑centered, and built for the unique demands of rare, ultra-rare, and orphan disease patients and their caregivers.

"Rare disease patients require more than a standard pharmacy experience; they deserve a dedicated care team that truly understands their journey," said Drew Walk, CEO of Soleo Health. "SoleoRare is the natural evolution of everything we have built. It highlights our rare disease capabilities, experience, and expertise.”

Soleo Health has long recognized that rare disease patients require a fundamentally different level of care. For years, the company has invested in clinical expertise, patient support capabilities, and the commercial infrastructure necessary to serve this population with the rigor it demands. The launch of SoleoRare reflects that ongoing commitment, uniting dedicated resources to deliver exceptional outcomes for patients, caregivers, providers, payors, and pharmaceutical manufacturer partners.

“Pharma partners developing rare and orphan therapies require a more specialized distribution channel, they need a true clinical and commercial partner," said Craig Vollmer, chief commercial officer. "SoleoRare was built to be exactly that. With dedicated teams focused on rare disease, we are positioned to deliver a meaningful impact on our patients’ experience."

• Related: Soleo Health to broaden rare disease portfolio with new exec